BERTI, EMILIO
 Distribuzione geografica
Continente #
NA - Nord America 19.736
AS - Asia 8.072
EU - Europa 6.164
SA - Sud America 1.381
AF - Africa 200
Continente sconosciuto - Info sul continente non disponibili 177
OC - Oceania 11
Totale 35.741
Nazione #
US - Stati Uniti d'America 18.571
SG - Singapore 2.773
CN - Cina 1.776
HK - Hong Kong 1.406
IT - Italia 1.306
RU - Federazione Russa 1.047
BR - Brasile 1.033
CA - Canada 918
VN - Vietnam 891
UA - Ucraina 850
SE - Svezia 672
IE - Irlanda 655
DE - Germania 456
GB - Regno Unito 330
FR - Francia 284
BD - Bangladesh 223
FI - Finlandia 202
IN - India 164
KR - Corea 152
NL - Olanda 137
AR - Argentina 119
IQ - Iraq 98
TR - Turchia 84
ZA - Sudafrica 74
JP - Giappone 71
MX - Messico 57
ID - Indonesia 54
SA - Arabia Saudita 54
EC - Ecuador 52
PK - Pakistan 52
AT - Austria 47
CO - Colombia 44
PH - Filippine 44
VE - Venezuela 42
CR - Costa Rica 37
ES - Italia 37
UZ - Uzbekistan 37
JM - Giamaica 31
BE - Belgio 25
DK - Danimarca 25
PY - Paraguay 25
CL - Cile 24
MA - Marocco 24
PL - Polonia 21
KE - Kenya 20
MY - Malesia 20
TT - Trinidad e Tobago 19
IR - Iran 18
PE - Perù 18
HN - Honduras 17
TN - Tunisia 17
IL - Israele 16
NP - Nepal 16
TH - Thailandia 16
EG - Egitto 15
ET - Etiopia 15
SV - El Salvador 15
NI - Nicaragua 14
TW - Taiwan 14
AE - Emirati Arabi Uniti 13
GT - Guatemala 13
CW - ???statistics.table.value.countryCode.CW??? 12
PR - Porto Rico 12
UY - Uruguay 12
AZ - Azerbaigian 11
BO - Bolivia 11
AL - Albania 9
AU - Australia 9
CH - Svizzera 9
DZ - Algeria 9
JO - Giordania 9
PS - Palestinian Territory 9
GR - Grecia 8
KZ - Kazakistan 7
PA - Panama 7
BG - Bulgaria 6
CZ - Repubblica Ceca 6
GP - Guadalupe 6
KG - Kirghizistan 6
OM - Oman 6
RO - Romania 6
AM - Armenia 5
EE - Estonia 5
EU - Europa 5
GE - Georgia 5
HU - Ungheria 5
SN - Senegal 5
BB - Barbados 4
BH - Bahrain 4
KH - Cambogia 4
LT - Lituania 4
LY - Libia 4
SC - Seychelles 4
BS - Bahamas 3
DO - Repubblica Dominicana 3
KW - Kuwait 3
XK - ???statistics.table.value.countryCode.XK??? 3
GA - Gabon 2
HR - Croazia 2
MD - Moldavia 2
Totale 35.542
Città #
Ann Arbor 1.860
Ashburn 1.789
Woodbridge 1.769
Singapore 1.481
Hong Kong 1.388
Houston 1.117
Fairfield 1.083
Jacksonville 936
San Jose 710
Dublin 607
Chandler 527
Toronto 494
Seattle 471
Council Bluffs 467
Santa Clara 467
Wilmington 444
New York 408
Cambridge 372
Milan 353
Princeton 351
Dearborn 312
Chicago 300
Beijing 282
The Dalles 240
Ho Chi Minh City 219
Hanoi 200
Hefei 187
Frankfurt am Main 174
Los Angeles 171
Lachine 169
Lawrence 165
Nanjing 161
Altamura 156
Lauterbourg 146
Seoul 141
Dallas 134
Moscow 117
São Paulo 107
Rome 102
Buffalo 90
San Diego 82
Dong Ket 74
Huizen 71
Andover 66
Guangzhou 66
Shanghai 63
Boardman 55
Rio de Janeiro 54
Norcross 53
Munich 49
Shenyang 48
Nanchang 47
Phoenix 43
Hebei 40
Detroit 39
Ottawa 39
North Bergen 38
Haiphong 37
Baghdad 36
Jiaxing 36
Da Nang 35
London 35
Montreal 35
Vienna 34
Atlanta 33
Brooklyn 33
Changsha 31
Orem 31
Tokyo 31
Naples 30
Norwalk 30
Tashkent 30
Tianjin 30
Salt Lake City 29
Helsinki 28
Philadelphia 28
Columbus 27
Mountain View 27
Las Vegas 26
Johannesburg 25
Amsterdam 24
Belo Horizonte 24
St Louis 24
Tampa 24
Turin 23
Dhaka 22
Bologna 21
Boston 21
Kingston 21
Quito 21
Brasília 20
Denver 20
Miami 20
Washington 20
Elk Grove Village 18
Falls Church 18
San Francisco 18
San José 18
The Bronx 18
University Park 18
Totale 22.724
Nome #
Interleukin-17-producing t-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation 400
Unusual variants of non-Langerhans cell histiocytosis 334
Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas 313
Primary cutaneous diffuse large B-cell lymphoma (PCDLBCL), leg-type and other: an update on morphology and treatment 296
Mutant p53 subverts p63 control over KLF4 expression in keratinocytes 289
Increased risk of venous thromboembolism in patients with bullous pemphigoid: The INVENTEP (INcidence of VENous Thromboembolism in bullous Pemphigoid) study 285
CaloCube: A new-concept calorimeter for the detection of high-energy cosmic rays in space 276
POF1B Localizes to Desmosomes and Regulates Cell Adhesion in Human Intestinal and Keratinocyte Cell Lines 274
Clinicopathological and molecular study of primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma 274
The CALOCUBE project for a space based cosmic ray experiment: Design, construction, and first performance of a high granularity calorimeter prototype 274
Elevated circulating CA 15.3 levels in a subset of systemic sclerosis with severe lung involvement 273
Granulomatous vasculitis 273
Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study 272
Aggressive epidermotropic cutaneous CD8+ lymphoma: A cutaneous lymphoma with distinct clinical and pathological features. Report of an EORTC Cutaneous Lymphoma Task Force Workshop 272
Photopheresis in cutaneous T-cell lymphoma: five-year experience 264
La giunzione dermo-epidermica 262
Activation of coagulation in bullous pemphigoid and other eosinophil-related inflammatory skin diseases 262
Effects of cyclophosphamide and IL-2 on regulatory CD4+ T cell frequency and function in melanoma patients vaccinated with HLA-class i peptides: Impact on the antigen-specific T cell response 262
Expression of cell cycle regulatory proteins and analysis of apoptosis in normal nasal mucosa and in nasal polyps 261
Radiotherapy of cutaneous B cell lymphomas: Our experience in 31 cases 260
bcl-1, bcl-2, p53, c-myc, and lyt-10 analysis in cutaneous lymphomas 256
Subcutaneous panniculitis-like T-cell lymphoma 256
Cutaneous lymphoma international consortium study of outcome in advanced stages of mycosis fungoides and sézary syndrome: Effect of specific prognostic markers on survival and development of a prognostic model 254
Paraneoplastic pemphigus. A report of two cases associated with chronic B-cell lymphocytic leukaemia 253
Detection of Polyomavirus in Merkel cell carcinoma by immunohistochemistry: report of three cases 252
Molecular analysis of cutaneous B- and T-cell lymphomas 250
Activation of blood coagulation in two prototypic autoimmune skin diseases: A possible link with thrombotic risk 249
To classify or to discern? That's the problem 246
Paradoxical Autoinflammatory Skin Reaction to Tumor Necrosis Factor Alpha Blockers Manifesting as Amicrobial Pustulosis of the Folds in Patients with Inflammatory Bowel Diseases 245
Onycolemmal carcinoma 244
Medallion-like dermal dendrocyte hamartoma: a case misdiagnosed as neurofibroma 244
Cutaneous lymphoid hyperplasia associated with Leishmania panamensis infection 243
Sézary Syndrome in a 17-Year-Old Boy: Clinicopathologic Features and Genomic Profile 243
Thalidomide treatment for hypertrophic cutaneous lupus erythematosus 242
Cytokine and chemokine profile in amicrobial pustulosis of the folds evidence for autoinflammation 242
Sneddon's syndrome: clinical and immunohistochemical findings 241
Chronic bullous disease of childhood and ulcerative colitis 240
New monoclonal antibodies against B-cell antigens: Possible new strategies for diagnosis of primary cutaneous B-cell lymphomas 239
EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma 239
Heteroduplex analysis of T-cell receptor gamma gene rearrangements for diagnosis and monitoring of cutaneous T-cell lymphomas 238
Absence of MYD88 L265P mutation in blastic plasmacytoid dendritic cell neoplasm 236
Skin involvement in cutaneous and systemic vasculitis 235
Natural killer and t-cell cytotoxic cutaneous lymphomas 234
Simultaneous onset of primary cutaneous B-cell lymphoma and human herpesvirus 8-associated Kaposi's sarcoma 232
Time course, clinical pathways, and long-term hazards risk trends of disease progression in patients with classic mycosis fungoides: A multicenter, retrospective follow-up study from the Italian Group of Cutaneous Lymphomas 231
Angiocentric and intravascular lymphomas 231
Diagnosis and disease severity assessment of epidermolysis bullosa acquisita by ELISA for anti-type VII collagen autoantibodies: an Italian multicentre study 231
JAK2-mutated Langerhans cell histiocytosis associated with primary myelofibrosis treated with ruxolitinib 231
WHO/EORTC classification of cutaneous lymphomas 2005: Histological and molecular aspects 229
Pustular skin reaction to tumor necrosis factor alpha antagonists in patients with inflammatory bowel diseases 227
CD30/Ki-1-positive lymphoproliferative disorders of the skin - Clinicopathologic correlation and statistical analysis of 86 cases: A multicentric study from the European organization for research and treatment of cancer cutaneous lymphoma project group 227
Paraneoplastic pemphigus associated with follicular dendritic cell sarcoma and Castelmann disease 226
Kaposi's sarcoma and herpes virus like DNA sequences in sensory ganglia 225
Primary cutaneous CD30‐positive large cell lymphoma: Definition of a new type of cutaneous lymphoma with a favorable prognosis. A European multicenter study of 47 patients 225
Primary cutaneous large B-cell lymphoma of the leg: Histogenetic analysis of a controversial clinicopathologic entity 224
Unique digital skin lesions associated with systemic sclerosis 224
Ichthyosis Curth-Macklin: a new sporadic case with immunohistochemical study of keratin expression 223
Lichen striatus – a chameleon: An histopathological and immunohistological study of forty‐one cases 223
C/EBPd Gene Targets in Human Keratinocytes 222
HHV8 cell associated viraemia and clinical presentation of mediterranean Kaposi's sarcoma 221
Immunohistochemical study of skin lesions in acute and chronic graft versus host disease following bone marrow transplantation 221
Human epidermal Langerhans cells express the ICAM-3 molecule. Immunohistochemical and immunoelectron microscopical demonstration 221
Treatment of advanced mycosis fungoides by allogeneic stem-cell transplantation with a nonmyeloablative regimen 221
The perikaryal surface of spinal ganglion neurons: differences between domains in contact with satellite cells and in contact with the extracellular matrix 220
Lupus erythematosus with antiphospholipid syndrome and erythema multiforme-like lesions 220
Inflammatory cells, cytokines and matrix metalloproteinases in amicrobial pustulosis of the folds and other neutrophilic dermatoses 219
Oncogenesis in HIV-infection 219
Reduced-intensity conditioning allogeneic haematopoietic stem cell transplantation in advanced mycosis fungoides and Sezary syndrome 218
Eruption resembling erythema gyratum repens in linear IgA dermatosis 218
Unilesional follicular mycosis fungoides 216
CD30-positive multilobated peripheral T-cell lymphoma primarily involving the subcutaneous tissue 215
Altered expression of a new antigen of the dermal-epidermal junction (NU-T2 DEJ Ag) in junctional epidermolysis bullosa 215
CLIPI: a new prognostic index for indolent cutaneous B cell lymphoma proposed by the International Extranodal Lymphoma Study Group (IELSG 11) 215
Subcutaneous 'lipoma-like' B-cell lymphoma associated with HCV infection: a new presentation of primary extranodal marginal zone B-cell lymphoma of MALT 213
Cutaneous CD30+ lymphoproliferative disorders: expression of bcl-2 and proteins of the tumor necrosis factor receptor superfamily 213
Differenital virual protein expression in Kasposi's sarcoma associated herpesvirus-infected disease: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease 211
Three cases of primary cutaneous lymphoblastic lymphoma: microarray-based comparative genomic hybridization and gene expression profiling studies with review of literature 210
Immunohistochemical evidence of cytokine networks during progression of human melanocytic lesions 210
Heterogeneity of spindle cells in Kaposi's sarcoma: comparison of cells in lesions and in culture 210
Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas: A distinct clinicopathological entity with an aggressive clinical behavior 207
Role of inflammatory cells, cytokines and matrix metalloproteinases in neutrophil-mediated skin diseases 206
Cytophagic histiocytic panniculitis and subcutaneous panniculitis-like t-lymphoma: report of 7 cases 205
Peristomal bullous pemphigoid 205
Cutaneous extranodal NK/T-cell lymphoma: a clinicopathologic study of 5 patients with array-based comparative genomic hybridization 205
Oral and cutaneous findings are valuable diagnostic aids in Wegener's granulomatosis 203
Parapsoriasis in Two Children: A Clinical, Immunophenotypic, and Immunogenotypic Study 202
Mycosis fungoides: disease evolution of the "lion queen" revisited 202
High sensitivity of human epidermal keratinocytes (HaCaT) to topoisomerase inhibitors 200
Primary cutaneous peripheral T-cell lymphomas, rare subtypes 199
Structural alterations of the NF-κB transcription factor lyt-10 in lymphoid malignancies 199
Experimental vitreous replacement with perfluorophenanthrene 199
Human herpesvirus-8 in AIDS-related and unrelated lymphomas 198
Unusual hyperpigmentation developing in congenital reticular ichthyosiform erythroderma (ichthyosis variegata) 198
Cutaneous T-cell lymphomas (including rare subtypes). Current concepts. II 197
Prevalence of Chlamydial Infection in a Series of 108 Primary Cutaneous Lymphomas 197
Prevalence of Borrelia burgdorferi infection in a series of 98 primary cutaneous lymphomas 196
Fibrogenic cytokines in vulvar lichen sclerosus: An immunohistochemical study 196
Immunohistochemical localization of a novel beta 1 integrin in normal and pathologic squamous epithelia 196
Science with the space-based interferometer eLISA: Supermassive black hole binaries 196
Delta chain-positive T-cell lymphoma of the skin 195
Totale 23.455
Categoria #
all - tutte 121.644
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 121.644


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022882 0 0 0 0 65 66 53 75 153 82 123 265
2022/20232.462 416 607 173 156 240 455 15 104 204 9 50 33
2023/20241.634 60 50 46 22 272 482 334 24 207 19 9 109
2024/20254.520 282 794 257 194 394 65 282 137 368 651 248 848
2025/202610.308 825 843 864 1.114 929 591 1.220 732 888 842 798 662
2026/20274.132 393 514 1.037 1.723 465 0 0 0 0 0 0 0
Totale 35.741